Skip to Content

Hydralazine injection

Last Updated: April 14, 2020
Status: Current

Products Affected - Description
    • Hydralazine injection, Akorn, 20 mg/mL, 1 mL vial, 25 count, NDC 17478-0934-15
    • Hydralazine injection, X-Gen, 20 mg/mL, 1 mL vial, 25 count, NDC 39822-0500-04
Reason for the Shortage
    • Akorn did not provide a reason for the shortage.
    • American Regent is not currently marketing hydralazine injection.
    • Fresenius Kabi has hydralazine available.
    • X-Gen did not provide a reason for the shortage.
Available Products
    • Hydralazine injection, Fresenius Kabi, 20 mg/mL, 1 mL vial, 25 count, NDC 63323-0614-01

Estimated Resupply Dates

    • Akorn has hydralazine 20 mg/mL 1 mL vials on back order and the company estimates a release date of early-May 2020. The company is allocating upon release.
    • X-Gen has hydralazine 20 mg/mL 1 mL vials on back order and the company cannot estimate a release date.

Updated

Updated April 14, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 4, 2018 by Anthony Trovato, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide